SEBASTIANI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 6.614
EU - Europa 5.215
AS - Asia 2.284
SA - Sud America 357
AF - Africa 50
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.533
Nazione #
US - Stati Uniti d'America 6.557
RU - Federazione Russa 1.173
GB - Regno Unito 1.051
IT - Italia 985
CN - Cina 813
SG - Singapore 753
IE - Irlanda 689
SE - Svezia 322
BR - Brasile 301
UA - Ucraina 239
HK - Hong Kong 212
DE - Germania 192
FR - Francia 169
VN - Vietnam 140
FI - Finlandia 128
KR - Corea 119
ES - Italia 77
IN - India 77
BE - Belgio 50
NL - Olanda 41
CA - Canada 27
PK - Pakistan 27
TR - Turchia 25
BD - Bangladesh 23
MX - Messico 22
JP - Giappone 17
AT - Austria 16
PL - Polonia 16
CZ - Repubblica Ceca 15
AR - Argentina 14
IQ - Iraq 13
IR - Iran 12
VE - Venezuela 11
CI - Costa d'Avorio 10
EC - Ecuador 10
ZA - Sudafrica 10
AU - Australia 9
GR - Grecia 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
LT - Lituania 7
MA - Marocco 7
IL - Israele 6
CO - Colombia 5
JO - Giordania 5
RO - Romania 5
SA - Arabia Saudita 5
CL - Cile 4
DK - Danimarca 4
KE - Kenya 4
LU - Lussemburgo 4
MY - Malesia 4
PE - Perù 4
BY - Bielorussia 3
CH - Svizzera 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
KG - Kirghizistan 3
PY - Paraguay 3
UZ - Uzbekistan 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
EE - Estonia 2
ID - Indonesia 2
IM - Isola di Man 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
NO - Norvegia 2
PH - Filippine 2
PT - Portogallo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MT - Malta 1
PA - Panama 1
PG - Papua Nuova Guinea 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SX - ???statistics.table.value.countryCode.SX??? 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 14.529
Città #
Dallas 1.761
Southend 930
Dublin 682
Fairfield 674
Ashburn 524
Singapore 439
Moscow 330
Chandler 318
Santa Clara 313
Woodbridge 274
Siena 268
Houston 262
Beijing 237
Cambridge 228
Hong Kong 212
Wilmington 208
Seattle 201
Jacksonville 187
Ann Arbor 153
Hefei 140
Seoul 116
New York 110
Princeton 100
Los Angeles 87
Florence 86
Nanjing 76
Milan 75
Dong Ket 64
Munich 64
The Dalles 61
Helsinki 59
Málaga 51
Shanghai 47
Rome 40
San Diego 38
Boardman 33
Buffalo 30
São Paulo 29
San Mateo 28
Council Bluffs 26
Turku 26
Ho Chi Minh City 25
London 24
Brussels 22
Columbus 21
Bengaluru 20
Dearborn 19
Lauterbourg 19
Redondo Beach 19
Washington 19
Chicago 18
Fremont 18
Nanchang 18
Nuremberg 18
Chennai 16
Leuven 16
Phoenix 16
Frankfurt am Main 15
Lappeenranta 15
Warsaw 15
Changsha 14
Düsseldorf 14
Hanoi 14
Zhengzhou 14
Montreal 13
Portsmouth 13
Atlanta 12
Brno 12
Brooklyn 12
Izmir 12
Pisa 12
Jiaxing 11
Redwood City 11
Tokyo 11
Verona 11
Abidjan 10
Denver 10
Dhaka 10
Hebei 10
Lahore 10
Redmond 10
San Francisco 10
Falls Church 9
Kraainem 9
Shenyang 9
Vienna 9
Enfield 8
Guangzhou 8
Karachi 8
Mexico City 8
Mori 8
Saronno 8
Turin 8
Udine 8
Amsterdam 7
Aracaju 7
Boston 7
Kunming 7
Stockholm 7
Tianjin 7
Totale 10.338
Nome #
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cells 1.195
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 300
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 288
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 288
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 276
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 271
Lymphocyte-derived exosomal microRNAs promote pancreatic β-cell death and may contribute to type 1 diabetes development. 268
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 267
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes 263
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 260
Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p 260
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 256
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 253
Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives 252
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 248
MicroRNA expression analysis of in vitro dedifferentiated human pancreatic islet cells reveals the activation of the pluripotency-related microRNA cluster miR-302s 246
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 243
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 239
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 224
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 223
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 220
Delta-cell specific expression of Hedgehog pathway Ptch1 receptor in murine and human endocrine pancreas 219
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 218
Prognostic bioindicators in severe COVID-19 patients 217
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion 204
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 200
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 199
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic bh3-only proteins DP5 and PUMA in human pancreatic β-cells 198
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 195
Coxsackieviruses and Insulitis 193
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 189
The Landscape of microRNAs in βCell: between phenotype maintenance and protection 187
Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. 183
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes 180
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells 180
Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors 178
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside 178
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 176
Non-coding RNAs: novel players in insulin resistance and related diseases 176
Viral Infections and diabetes 174
The case for virus-induced type 1 diabetes 172
MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapy 171
Dietary supplementation with high doses of regular vitamin D3 safely reduces Diabetes incidence in nod mice when given early and long-term. 170
Enteroviral Infections and Development of Type 1 Diabetes: The Brothers Karamazov Within the CVBs 166
Circulating microRNAs signature for predicting response to GLP1-RA therapy in Type 2 diabetic patients: a pilot study 163
Virus infections: lessons from pancreas histology 163
Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors 162
MicroRNA circolanti come biomarcatori per il diabete mellito di tipo 2: avanzamenti e prospettive future 160
Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes 160
SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature 159
Multi-Omics Integrative Approach of Extracellular Vesicles: A Future Challenging Milestone 155
Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function 153
Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity 152
Common molecular pathways targeted by nintedanib in cancer and IPF: a bioinformatic study 152
A three-layer perspective on miRNA regulation in β cell inflammation 151
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 149
Microbioma intestinale e diabete mellito 147
Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation 144
A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes 142
null 128
Extracellular vesicles in immune system regulation and Type 1 diabetes: cell-to-cell communication Mediators, disease biomarkers, and promising therapeutic tools 118
Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples 116
CD8+ T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes 112
MicroRNAs: Novel players in the dialogue between pancreatic islets and immune system in autoimmune diabetes 109
NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes 109
Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis 106
null 106
Micro-RNA expression profiling in Paget's disease of bone 106
Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis 100
Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomy 96
Intestinal Delivery of Proinsulin and IL-10 via Lactococcus lactis Combined With Low-Dose Anti-CD3 Restores Tolerance Outside the Window of Acute Type 1 Diabetes Diagnosis 95
null 90
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 88
Multi‐omics analysis reveals drivers of loss of β‐cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study 85
Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child 85
null 79
Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes 70
Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo 59
Totale 14.832
Categoria #
all - tutte 43.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021866 0 0 0 0 0 96 109 169 137 151 91 113
2021/2022913 72 131 61 100 39 31 39 30 38 78 113 181
2022/20231.318 72 133 134 158 140 281 31 85 108 66 62 48
2023/20241.243 39 49 111 74 58 340 375 39 6 62 15 75
2024/20252.415 49 128 276 148 314 153 108 138 230 111 229 531
2025/20264.618 429 696 1.674 685 1.091 43 0 0 0 0 0 0
Totale 14.832